Viridian Therapeutics, Inc.\DE — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Fairmount Healthcare Fund II GP LLC | — | Purchase | 454,545 | $22.00 | $9,999,990 | 3,914,458 | Oct 23, 2025 |
| Fairmount Funds Management LLC | — | Option Exercise | 12,500 | $12.31 | $153,875 | 3,459,913 | Jun 9, 2025 |
| Beetham Thomas W. | Chief Operating Officer | Purchase | 5,000 | $23.41 | $117,050 | 6,000 | Sep 27, 2024 |
| Mahoney Stephen F. | President and CEO | Purchase | 21,400 | $23.33 | $499,262 | 21,400 | Sep 27, 2024 |
| Fairmount Healthcare Fund II L.P. | — | Purchase | 1,600,000 | $18.75 | $30,000,000 | 3,445,813 | Sep 13, 2024 |
| Fairmount Healthcare Fund II L.P. | — | Other | 5,859 | — | — | 1,845,813 | Mar 28, 2024 |
| Fairmount Healthcare Fund II L.P. | — | Purchase | 476,190 | $21.00 | $9,999,990 | 1,839,954 | Jan 22, 2024 |
| Meisner Lara | Chief Legal Officer | Option Exercise | 27 | $23.03 | $622 | 29,998 | Jun 15, 2023 |
| Meisner Lara | Chief Legal Officer | Option Exercise | 499 | $18.51 | $9,236 | 30,470 | Jun 2, 2023 |
| Myers Scott Dunseth | Chief Executive Officer | Purchase | 4,000 | $25.37 | $101,480 | 259,500 | Apr 12, 2023 |
| Myers Scott Dunseth | Chief Executive Officer | Purchase | 5,500 | $29.15 | $160,325 | 255,500 | Mar 13, 2023 |
| Meisner Lara | General Counsel and Secretary | Sale | 29,971 | $29.07 | $871,257 | — | Mar 9, 2023 |
| Myers Scott Dunseth | Chief Executive Officer | Award / Grant | 250,000 | — | — | 250,000 | Feb 6, 2023 |
| Violin Jonathan | Chief Executive Officer | Option Exercise | 50,000 | $0.15 | $7,500 | 530,905 | Feb 2, 2023 |
| Violin Jonathan | Chief Executive Officer | Sale | 50,000 | $36.80 | $1,840,000 | 430,905 | Feb 2, 2023 |
| Meisner Lara | General Counsel and Secretary | Option Exercise | 1,872 | $14.00 | $26,208 | 6,843 | Jan 23, 2023 |
| Katz Barrett | Chief Medical Officer | Sale | 4,147 | $37.01 | $153,480 | — | Jan 17, 2023 |
| Katz Barrett | Chief Medical Officer | Sale | 47,377 | $35.30 | $1,672,408 | — | Jan 9, 2023 |
| Meisner Lara | General Counsel and Secretary | Sale | 16,326 | $29.19 | $476,556 | — | Dec 20, 2022 |
| Meisner Lara | General Counsel and Secretary | Sale | 1,297 | $28.44 | $36,887 | — | Dec 15, 2022 |
| Meisner Lara | General Counsel and Secretary | Sale | 15,656 | $28.12 | $440,247 | — | Dec 14, 2022 |
| Meisner Lara | General Counsel and Secretary | Option Exercise | 8,125 | $14.00 | $113,750 | 8,125 | Nov 15, 2022 |
| Fairmount Healthcare Fund GP LLC | — | Purchase | 425,531 | $23.50 | $9,999,979 | 1,363,764 | Aug 17, 2022 |
| Violin Jonathan | Chief Executive Officer | Sale | 30,000 | $12.20 | $366,000 | 480,905 | Jun 1, 2022 |
| Violin Jonathan | Chief Executive Officer | Sale | 30,000 | $13.04 | $391,200 | 510,905 | May 2, 2022 |
| Violin Jonathan | Chief Executive Officer | Sale | 3,600 | $18.93 | $68,148 | 540,905 | Apr 1, 2022 |
| Violin Jonathan | Chief Executive Officer | Sale | 18,894 | $17.82 | $336,691 | 582,011 | Mar 2, 2022 |
| Violin Jonathan | Chief Executive Officer | Sale | 909 | $19.16 | $17,416 | 600,905 | Feb 1, 2022 |
| Violin Jonathan | See Remarks | C | 627,564 | — | — | 630,905 | Dec 8, 2021 |
| Frazier Life Sciences Public Fund, L.P. | — | Purchase | 200,000 | $11.00 | $2,200,000 | 1,505,200 | Sep 23, 2021 |
| Fairmount Healthcare Fund L.P. | — | Purchase | 909,000 | $11.00 | $9,999,000 | 938,233 | Sep 21, 2021 |
| Logos Global Master Fund LP | — | Purchase | 100,000 | $1.16 | $116,000 | 6,350,000 | Nov 13, 2020 |
| Fairmount Healthcare Fund II L.P. | — | Other | 438,502 | — | — | 438,502 | Oct 27, 2020 |
| Violin Jonathan | President and COO | Other | 50,124 | — | — | 50,124 | Oct 27, 2020 |
| Leverone Jason A. | CFO, Treasurer & Secretary | Option Exercise | 11,249 | $0.57 | $6,412 | 48,829 | Mar 13, 2020 |
| Leverone Jason A. | CFO, Treasurer & Secretary | Option Exercise | 3,093 | $0.57 | $1,763 | 36,330 | Aug 23, 2019 |
| Marshall William Stuart | President & CEO | Award / Grant | 1,250 | $1.14 | $1,425 | 270,646 | Feb 21, 2019 |
| Hughes Thomas E. | — | Purchase | 10,000 | $4.77 | $47,700 | 12,827 | Oct 11, 2018 |
| Leverone Jason A. | CFO, Treasurer & Secretary | Option Exercise | 29,530 | $0.57 | $16,832 | 30,737 | Aug 7, 2018 |
| Booth Bruce | — | Purchase | 545,454 | $5.50 | $2,999,997 | 1,351,090 | Feb 13, 2018 |
| Levy Adam Scott | Chief Business Officer | Purchase | 9,090 | $5.50 | $49,995 | 10,540 | Feb 13, 2018 |
| Marshall William Stuart | President & CEO | Option Exercise | 115,818 | $0.57 | $66,016 | 265,646 | Feb 13, 2018 |
| Hughes Thomas E. | — | Sale | 12,000 | $8.00 | $96,000 | 2,827 | Dec 20, 2017 |
| Levy Adam Scott | Chief Business Officer | Purchase | 200 | $7.55 | $1,510 | 200 | Jun 22, 2017 |
| Hughes Thomas E. | — | Award / Grant | 778 | — | — | 14,840 | Mar 24, 2017 |
| LEFKOFF KYLE | — | Sale | 2,500 | $14.38 | $35,950 | 466,773 | Mar 10, 2017 |
| LEFKOFF KYLE | — | Sale | 9,392 | $15.71 | $147,548 | 474,881 | Mar 8, 2017 |
| LEFKOFF KYLE | — | Sale | 6,500 | $14.04 | $91,260 | 488,031 | Feb 28, 2017 |
| LEFKOFF KYLE | — | Sale | 4,102 | $14.36 | $58,905 | 496,331 | Feb 23, 2017 |
| LEBOW BENNETT S | — | Option Exercise | 279,067 | $5.39 | $1,504,171 | 280,600 | Feb 13, 2017 |